Search
Descriptor English: Lenalidomide
Descriptor Spanish: Lenalidomida
Descriptor lenalidomida
Entry term(s) 2,6-piperidinediona, 3-(4-amino-1,3-dihidro-1-oxo-2H- isoindol-2-il)-
3-(4-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona
CC 5013
CC-5013
CC5013
IMiD3 Cpd
revimid
revlimid
Scope note: Derivado de ftalimida y piperidona que posee propiedades inmunomoduladoras y antiangiogénicas. Se usa para el tratamiento de la anemia dependiente de transfusiones en los SÍNDROMES MIELODISPLÁSICOS y para el tratamiento del MIELOMA MÚLTIPLE y del LINFOMA DE CÉLULAS DEL MANTO recidivante o resistente al tratamiento.
Descriptor Portuguese: Lenalidomida
Descriptor French: Lénalidomide
Entry term(s): 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
CC 5013
CC-5013
CC5013
IMiD3 Cpd
Revimid
Revlimid
Tree number(s): D02.241.223.805.810.400
D03.383.621.808.519
D03.633.100.513.750.563
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077269
Scope note: A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Immunologic Factors
Angiogenesis Inhibitors
Registry Number: F0P408N6V4
Public MeSH Note: 2019; LENALIDOMIDE was indexed under THALIDOMIDE/analogs & derivatives 2002-2018
History Note: 2019 (2002)
DeCS ID: 57572
Unique ID: D000077269
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/02/27
Lenalidomide - Preferred
Concept UI M0479831
Scope note A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA.
Preferred term Lenalidomide
Entry term(s) 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
IMiD3 Cpd
CC 5013 - Narrower
Concept UI M0441604
Preferred term CC 5013
Entry term(s) CC-5013
CC5013
Revlimid - Narrower
Concept UI M0450897
Preferred term Revlimid
Entry term(s) Revimid



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey